5-Benzylidene-3-ethyl rhodanine

• CAT Number: M086298
• CAS Number: 18331-34-5
• Molecular Formula: C12H11NOS2
• Molecular Weight: 249.35
• Purity: ≥95%
• Target: Apoptosis
• Storage: 2-8°C
• IUPAC Name: (1S,2R,9S,10R,12S)-4,9-dimethyl-13-methylidene-6-oxatetracyclo[7.4.0.03,7.010,12]trideca-3(7),4-dien-2-ol
• InChI: InChI=1S/C15H18O2/c1-7-6-17-11-5-15(3)10-4-9(10)8(2)13(15)14(16)12(7)11/h6,9-10,13-14,16H,2,4-5H2,1,3H3/t9-,10-,13-,14+,15+/m1/s1
• InChIKey: XRDJYSVGPBJZSG-PSDLAXTLSA-N
• SMILES: CC1=COC2=C1C(C3C(=C)C4CC4C3(C2)C)O

BTR-1 is an effective anticancer agent known for inducing cell cycle arrest in the S-phase, disrupting DNA replication, and triggering apoptosis, ultimately resulting in cell death. Its mechanism of action involves interfering with the cell’s normal processes, specifically targeting DNA replication and promoting apoptosis, which is the programmed cell death pathway. The ability of BTR-1 to halt cell cycle progression and initiate apoptosis makes it a promising candidate for cancer treatment and warrants further investigation.